A patient presented with a progressive history of muscle weakness resulting in getting up from a chair and climbing steps. The physician also notices a lilac colored discoloration of the upper eyelids associated with periorbital edema. Laboratory evaluation reveals increased creatinine phosphokinase and a positive antinuclear antibody. Which of the following antibodies is most expected to be seen in this patient?

Okay, let's tackle this question. The patient has progressive muscle weakness, trouble getting up from a chair and climbing stairs. That makes me think of muscle disorders. The lilac discoloration and periorbital edema of the upper eyelids are classic signs of dermatomyositis. The lab results show elevated creatinine phosphokinase (CK), which is a muscle enzyme, and a positive ANA. So, the key here is to connect these findings to the specific autoantibody associated with dermatomyositis.

Dermatomyositis is an autoimmune condition that affects muscles and skin. The hallmark symptoms include proximal muscle weakness and the characteristic skin rashes. The presence of a positive ANA makes sense because ANA is common in autoimmune diseases. Now, the question is asking which specific antibody is most expected here.

Common autoantibodies in dermatomyositis include anti-Jo-1, anti-Mi-2, and others. However, the most classic one associated with the skin findings and muscle involvement is anti-Mi-2. Anti-Mi-2 is strongly linked to dermatomyositis with the heliotrope rash (the lilac eyelid discoloration) and periorbital edema. Another antibody associated is anti-Jo-1, which is more related to the overlap syndrome with interstitial lung disease, but the skin signs here point more towards anti-Mi-2.

Wait, but I should double-check. The options aren't listed, but the correct answer is supposed to be one of them. Let me think about other possibilities. Anti-Scl-70 is for scleroderma, anti-Smith for SLE, and anti-Ro for Sjögren's or lupus. So those are out. The key here is the dermatomyositis-specific antibodies. Anti-Mi-2 is the most specific for the skin manifestations. Therefore, the correct answer should be anti-Mi-2.

**Core Concept**
This question tests recognition of dermatomyositis, an inflammatory myopathy characterized by muscle weakness, heliotrope rash, and periorbital edema. Autoantibodies like anti-Mi-2 are pathognomonic for this condition.

**Why the Correct Answer is Right**
The patient’s symptoms (proximal muscle weakness, heliotrope rash, elevated CK, and ANA) strongly suggest dermatomyositis. Anti-Mi-2 antibodies are specifically associated with classic dermatomyositis, including skin manifestations like the lilac eyelid discoloration. These antibodies target the Mi-2 helicase enzyme, which is involved in chromatin remodeling.

**Why Each Wrong Option is Incorrect**
**Option A:** Anti-Jo-1 is linked to polymyositis, not dermatomyositis, and is associated with interstitial lung disease.
**Option B:** Anti-Scl-70 is specific for systemic sclerosis (scleroderma), causing skin thickening and vascular changes.
**Option C:** Anti-Smith is diagnostic for systemic lupus erythematosus (SLE), not myopathies.

**Clinical Pearl / High-Yield Fact**
Remember the "HUG" mnemonic for dermatomyositis: **H**eliotrope rash, **U**niform muscle weakness, **G**ottron

✓ Correct Answer: D. Anti-Mi2 antibodies